UUIIJ: 4F3E265C- 5229- 4336- BGCD- IDECFBBCGCFeSd
TCGA- CE- A485- BiA- PR
IIIII
IIII
IIII

IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIced
IIIIIIIIIIIIIIII I
|||||||I||||||IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII

Clinical Case Report

lab 0 ’5 (For Collection of Cancerous Tissue)
Cami/km {NLPI‘HM VLLV/Lvli.
(QM/3

5.1115 “Myra/0d, N05 @753

pa 7/94,”, IInformed ConseniI

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this inforrned consent document will be retained at
our institution

Name of Physician or Study Coordinator . Signature uaw

 

{Clinical InformationI

 

TI N -.;
T
:1 Single )nMarried V NA S

Gender n Divorced 1:1 Widow Blood Pressure Heart Rate
Male El Female . .L ‘

 

 

‘- ; 7 " - . ' - - . ‘ HISTORY QFVPRESENT ILLNESS ’
Chief Complaints: \j owl/Q $0M )F java. A
Symptoms: w 01‘ Q7401w C05;

Clinical Findings:

 

 

 

 

Performance Scale (Karnofsky Score): .
1:1 100 Asymptomatic 80-90 Symptomatic but Fully Ambulatory a 60-70 Symptomatic, in bed less than 50% of day
:1 40-50 S mptomatic, in bed more than 50% ofday, but not bed ridden :1 20-30 Bed Ridden

 

 

 

MED CATIONS ' .

 

 

PAST MEDICAL HISTORY

 

 

 

 

 

. ~ .- ‘ ‘ OBIGYNHISTORY' w - - I.
Menopausal Status Date of First Menses # of Pregnancies

El Pie-menopausal

1:1 Peri-Menopausal Date of Last Menses # of Live Births

 

U Post-menopausal

 

 

Birth Control: D Condom
El Other:

El Oral Contraceptive D IUD

_=

1:1 Hormone Replacement
Therapy:

 

 

YES El NO

YES Ci N0

Current

Cl YES NO

Relative

Alcohol

Duration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- - LAB DATA A ,v

Test Result I Date I I Test Result Date
HIV ‘pNegative [3 Positive: , CEA El Negative D Positive:

Hep B Iﬁ'INEgative D Positive: ’ - CA 15-3 D Negative 0 Positive:

Hep C b’Negative Cl Positive: CA 19-9 Cl Negative El Positive:
AF P E! Negative Cl Positive: PSA 0 Negative El Positive:

Other: Ci Negative D Positive: Other: Cl Negative D Positive:

B/T Cell Markers:

 

 

 

-' DIAGNOSTIC STUDIES

Results
Ultrasound

x-
CT

MRI

CAL DIAGN

Clinical
1' z N M 0 Stage: 3:—

 

 

ITreatment InformationI

CAL: , .
of Procedure ,

Prima‘ Tumor
Location

# of l. Nodes
Palpable, Non-Dissected Lymph Nodes

Dissected Lymph Nodes
Distant Metastasis

 

Collected by: .

Preserved by:

Frozen
Diseased Normal

Time to LN2

Notes:

Pathology Form

 

[Specimen Informatioﬂ

 

SPECIMEN ’ # of '
m/Plnsma
Normal Diseased Normal

Time to Formalin Time to LN2
min

PATHOLOGI ‘ ‘ D

Tumor
Size Extension of Distance to NAT

x ~x cm ‘ crn
Nodes
#Examlned

Distant Metastasis

Patho ical
[IT 2_ N Mo

 

CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM*

Microscopic Appearance:

1. '
CELL DISTRIBUTION
Diffuse
Mosaic
Necrosis
L Inﬁltration
Vascular Invasion
Clusterized '
Alveolar
Indian File . Psammoma/Calciﬁcation

2. Cellular

+ - + ~ L
Cell Glandular cell Round Cell
Cell Cell Fibroblast Small Cell

Kerstin Secretion Osteoblast RS Cell/RS Like
Desmosome Vacuole Inﬂam. Cell

Plasma Cell

Otherwise Speciﬁed: D .7

 

2. Cellular Di eremlatlou.‘

WelL Moderately Poor
1

 

 

 

 

 

 

 

3. Nuclear

    

Aniso Nucleosis

Prominent

Multinucleated Giant
Mitotic

Nuclear Grade

Histological Diagnosiszm MW @242th
Comments: Mr me MWFH9;3Q§ 7% (J0

*( INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AND . PATHOLOGIS T STAFF

 
  

RESEARCH USE ONLY).

  

\I7

